News and Announcements
Universal Biosensors Welcomes FDA Clearance for Xprecia Stride Analyzer
- Published October 06, 2016 12:03PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
5th October 2016, ASX Announcement
Universal Biosensors (ASX: UBI) today welcomes news that the US Food and Drug Administration (FDA) has cleared for sale in the US the Xprecia Stride Coagulation Analyzer which is produced by partner Siemens Healthineers and uses test strips developed and manufactured by UBI.
The Xprecia Stride analyser is a handheld device which delivers Prothrombin time international normalised ratio testing for point-of-care monitoring and assessment of patients taking oral anticoagulation therapy warfarin.
To view the full announcement, please click on the button below.
Company Updates
BlackRock has named the next Economy. What this latest paper means for Private Market Investors.
BlackRock has put a name on something the smart money has been circling for two years. Its digital assets research team calls it the machine-native economy. The thesis fits in one line. AI is machine-native intelligence. Digital assets are machine-native money. Both are built on the same architecture, and they are converging into a single […]
Where’s the beef? Blackstone just answered the AI question.
In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]
The Best of Both Worlds: How Omnique Fund is Rewiring Real World Assets via Tokenisation
For decades, the playbook for Australia’s wholesale investors has remained relatively unchanged: pick between the slow-moving, illiquid reliability of tangible assets like property and gold, or chase the frictionless, high-velocity liquidity of public equity and digital markets. But as macroeconomic volatility spikes and a structural housing deficit reshapes private debt demand, sophisticated investors are demanding […]
Backed By Leading Investment Groups and Family Offices
